Skip to main content
Erschienen in: European Radiology 7/2019

28.01.2019 | Chest

Computed tomography features of local pleural recurrence in patients with malignant pleural mesothelioma treated with intensity-modulated pleural radiation therapy

verfasst von: Darragh Halpenny, Micheal Raj, Andreas Rimner, Junting Zheng, Marinela Capanu, Michelle S. Ginsberg

Erschienen in: European Radiology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study was conducted in order to describe the computed tomography (CT) features of local pleural recurrence in patients with malignant pleural mesothelioma undergoing intensity-modulated pleural radiation therapy (IMPRINT) as part of multimodality treatment.

Methods

In this observational study, 58 patients treated with IMPRINT between September 21, 2004, and December 1, 2014 were included. Baseline and follow-up CT scans were qualitatively assessed. On follow-up scans, pleural thickening was categorized as unchanged, decreased, or new/increased. New/increased pleural abnormality was subcategorized as diffuse smooth pleural thickening, diffuse nodular pleural thickening, focal pleural nodule, or multiple pleural nodules. To identify features more frequently present at the time of local recurrence, follow-up scans with local recurrence were matched to four control scans; exact conditional logistic regression was performed.

Results

Twenty-one (36%) patients had local pleural recurrence and 20 (34%) patients had nonpleural recurrence; 3 patients had both types of recurrence. The 1-year cumulative incidence rate of local recurrence was 27% (95% confidence interval 15, 39). On follow-up scans, three patterns of pleural abnormality were significantly associated with local recurrence: new/increased multiple pleural nodules (10 (48%) positive scans vs 0 control scans), new/increased diffuse nodular pleural thickening (7 (33%) positive scans vs 1 (1%) control scans), and new/increased focal pleural nodule (3 (14%) positive scans vs 1 (1%) control scan) (p < 0.001 for all).

Conclusions

Multiple new/increased pleural nodules are the feature most commonly present at local recurrence following IMPRINT; however, any pattern of increased nodular pleural thickening is suspicious.

Key Points

• In patients with mesothelioma receiving intensity-modulated pleural radiation as part of multimodality therapy, increasing multiple pleural nodules is the computed tomography feature most commonly present at local recurrence.
• In these patients, any CT pattern of increased nodular pleural thickening should be considered suspicious for local recurrence.
• The most common sites of nonpleural recurrence were lung parenchyma, thoracic lymph nodes, and peritoneum.
Literatur
1.
Zurück zum Zitat Beebe-Dimmer JL, Fryzek JP, Yee CL et al (2016) Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival. Clin Epidemiol 8:743–750CrossRefPubMedPubMedCentral Beebe-Dimmer JL, Fryzek JP, Yee CL et al (2016) Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival. Clin Epidemiol 8:743–750CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Flores RM, Pass HI, Seshan VE et al (2008) Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 135:620–626 Flores RM, Pass HI, Seshan VE et al (2008) Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 135:620–626
4.
Zurück zum Zitat Batirel HF, Metintas M, Caglar HB et al (2016) Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy. J Thorac Cardiovasc Surg 151:478–484CrossRefPubMed Batirel HF, Metintas M, Caglar HB et al (2016) Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy. J Thorac Cardiovasc Surg 151:478–484CrossRefPubMed
5.
Zurück zum Zitat Rosenzweig KE, Zauderer MG, Laser B et al (2012) Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 83:1278–1283CrossRefPubMedPubMedCentral Rosenzweig KE, Zauderer MG, Laser B et al (2012) Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 83:1278–1283CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Chance WW, Rice DC, Allen PK et al (2015) Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis. Int J Radiat Oncol Biol Phys 91:149–156CrossRefPubMed Chance WW, Rice DC, Allen PK et al (2015) Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis. Int J Radiat Oncol Biol Phys 91:149–156CrossRefPubMed
7.
Zurück zum Zitat Shaikh F, Zauderer MG, von Reibnitz D et al (2017) Improved outcomes with modern lung-sparing trimodality therapy in patients with malignant pleural mesothelioma. J Thorac Oncol 12:993–1000CrossRefPubMedPubMedCentral Shaikh F, Zauderer MG, von Reibnitz D et al (2017) Improved outcomes with modern lung-sparing trimodality therapy in patients with malignant pleural mesothelioma. J Thorac Oncol 12:993–1000CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Mendiratta-Lala M, Gu E, Owen D et al (2018) Imaging findings within the first 12 months of hepatocellular carcinoma treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 102(4):1063–1069 Mendiratta-Lala M, Gu E, Owen D et al (2018) Imaging findings within the first 12 months of hepatocellular carcinoma treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 102(4):1063–1069
9.
Zurück zum Zitat Trovo M, Linda A, El Naqa I, Javidan-Nejad C, Bradley J (2010) Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT). Lung Cancer 69:77–85CrossRefPubMed Trovo M, Linda A, El Naqa I, Javidan-Nejad C, Bradley J (2010) Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT). Lung Cancer 69:77–85CrossRefPubMed
10.
Zurück zum Zitat Dahele M, Palma D, Lagerwaard F, Slotman B, Senan S (2011) Radiological changes after stereotactic radiotherapy for stage I lung cancer. J Thorac Oncol 6:1221–1228CrossRefPubMed Dahele M, Palma D, Lagerwaard F, Slotman B, Senan S (2011) Radiological changes after stereotactic radiotherapy for stage I lung cancer. J Thorac Oncol 6:1221–1228CrossRefPubMed
11.
Zurück zum Zitat Halpenny D, Ridge CA, Hayes S et al (2015) Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy. Clin Imaging 39:254–258CrossRefPubMed Halpenny D, Ridge CA, Hayes S et al (2015) Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy. Clin Imaging 39:254–258CrossRefPubMed
12.
Zurück zum Zitat Baldini EH, Richards WG, Gill RR et al (2015) Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 149:1374–1381CrossRefPubMedPubMedCentral Baldini EH, Richards WG, Gill RR et al (2015) Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 149:1374–1381CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Rimner A, Spratt DE, Zauderer MG et al (2014) Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 90:394–401CrossRefPubMedPubMedCentral Rimner A, Spratt DE, Zauderer MG et al (2014) Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 90:394–401CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Frauenfelder T, Tutic M, Weder W et al (2011) Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma? Eur Respir J 38:162–168CrossRefPubMed Frauenfelder T, Tutic M, Weder W et al (2011) Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma? Eur Respir J 38:162–168CrossRefPubMed
15.
Zurück zum Zitat Rusch VW, Gill R, Mitchell A et al (2016) A multicenter study of volumetric computed tomography for staging malignant pleural mesothelioma. Ann Thorac Surg 102:1059–1066CrossRefPubMedPubMedCentral Rusch VW, Gill R, Mitchell A et al (2016) A multicenter study of volumetric computed tomography for staging malignant pleural mesothelioma. Ann Thorac Surg 102:1059–1066CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Byrne MJ, Nowak AK (2004) Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 15:257–260CrossRefPubMed Byrne MJ, Nowak AK (2004) Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 15:257–260CrossRefPubMed
17.
Zurück zum Zitat Tan C, Barrington S, Rankin S et al (2010) Role of integrated 18-fluorodeoxyglucose position emission tomography-computed tomography in patients surveillance after multimodality therapy of malignant pleural mesothelioma. J Thorac Oncol 5:385–388CrossRefPubMed Tan C, Barrington S, Rankin S et al (2010) Role of integrated 18-fluorodeoxyglucose position emission tomography-computed tomography in patients surveillance after multimodality therapy of malignant pleural mesothelioma. J Thorac Oncol 5:385–388CrossRefPubMed
18.
Zurück zum Zitat Wang ZJ, Reddy GP, Gotway MB et al (2004) Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. Radiographics 24:105–119CrossRefPubMed Wang ZJ, Reddy GP, Gotway MB et al (2004) Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. Radiographics 24:105–119CrossRefPubMed
19.
Zurück zum Zitat Armato SG 3rd, Entwisle J, Truong MT et al (2008) Current state and future directions of pleural mesothelioma imaging. Lung Cancer 59:411–420CrossRefPubMed Armato SG 3rd, Entwisle J, Truong MT et al (2008) Current state and future directions of pleural mesothelioma imaging. Lung Cancer 59:411–420CrossRefPubMed
20.
Zurück zum Zitat Armato SG 3rd, Blyth KG, Keating JJ et al (2016) Imaging in pleural mesothelioma: a review of the 13th International Conference of the International Mesothelioma Interest Group. Lung Cancer 101:48–58CrossRefPubMed Armato SG 3rd, Blyth KG, Keating JJ et al (2016) Imaging in pleural mesothelioma: a review of the 13th International Conference of the International Mesothelioma Interest Group. Lung Cancer 101:48–58CrossRefPubMed
21.
Zurück zum Zitat Rusch VW, Godwin JD, Shuman WP (1988) The role of computed tomography scanning in the initial assessment and the follow-up of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 96:171–177PubMed Rusch VW, Godwin JD, Shuman WP (1988) The role of computed tomography scanning in the initial assessment and the follow-up of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 96:171–177PubMed
22.
Zurück zum Zitat Adams H, Butchart EG (1992) Computed tomographic assessment of patients following radical surgery for malignant mesothelioma. Clin Radiol 45:120–124CrossRefPubMed Adams H, Butchart EG (1992) Computed tomographic assessment of patients following radical surgery for malignant mesothelioma. Clin Radiol 45:120–124CrossRefPubMed
23.
Zurück zum Zitat Mirvis S, Dutcher JP, Haney PJ, Whitley NO, Aisner J (1983) CT of malignant pleural mesothelioma. AJR Am J Roentgenol 140:665–670CrossRefPubMed Mirvis S, Dutcher JP, Haney PJ, Whitley NO, Aisner J (1983) CT of malignant pleural mesothelioma. AJR Am J Roentgenol 140:665–670CrossRefPubMed
24.
Zurück zum Zitat van Klaveren RJ, Aerts JG, de Bruin H, Giaccone G, Manegold C, van Meerbeeck JP (2004) Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma. Lung Cancer 43:63–69CrossRefPubMed van Klaveren RJ, Aerts JG, de Bruin H, Giaccone G, Manegold C, van Meerbeeck JP (2004) Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma. Lung Cancer 43:63–69CrossRefPubMed
25.
Zurück zum Zitat Labby ZE, Straus C, Caligiuri P et al (2013) Variability of tumor area measurements for response assessment in malignant pleural mesothelioma. Med Phys 40:081916CrossRefPubMedPubMedCentral Labby ZE, Straus C, Caligiuri P et al (2013) Variability of tumor area measurements for response assessment in malignant pleural mesothelioma. Med Phys 40:081916CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Plathow C, Staab A, Schmaehl A et al (2008) Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results. Invest Radiol 43:737–744CrossRefPubMed Plathow C, Staab A, Schmaehl A et al (2008) Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results. Invest Radiol 43:737–744CrossRefPubMed
27.
Zurück zum Zitat Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247CrossRefPubMed Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247CrossRefPubMed
28.
Zurück zum Zitat Plathow C, Klopp M, Thieke C et al (2008) Therapy response in malignant pleural mesothelioma—role of MRI using RECIST, modified RECIST and volumetric approaches in comparison with CT. Eur Radiol 18:1635–1643CrossRefPubMed Plathow C, Klopp M, Thieke C et al (2008) Therapy response in malignant pleural mesothelioma—role of MRI using RECIST, modified RECIST and volumetric approaches in comparison with CT. Eur Radiol 18:1635–1643CrossRefPubMed
29.
Zurück zum Zitat Feigen M, Lee ST, Lawford C et al (2011) Establishing locoregional control of malignant pleural mesothelioma using high-dose radiotherapy and (18) F-FDG PET/CT scan correlation. J Med Imaging Radiat Oncol 55:320–332CrossRefPubMed Feigen M, Lee ST, Lawford C et al (2011) Establishing locoregional control of malignant pleural mesothelioma using high-dose radiotherapy and (18) F-FDG PET/CT scan correlation. J Med Imaging Radiat Oncol 55:320–332CrossRefPubMed
30.
Zurück zum Zitat Pilling J, Dartnell JA, Lang-Lazdunski L (2010) Integrated positron emission tomography-computed tomography does not accurately stage intrathoracic disease of patients undergoing trimodality therapy for malignant pleural mesothelioma. Thorac Cardiovasc Surg 58:215–219CrossRefPubMed Pilling J, Dartnell JA, Lang-Lazdunski L (2010) Integrated positron emission tomography-computed tomography does not accurately stage intrathoracic disease of patients undergoing trimodality therapy for malignant pleural mesothelioma. Thorac Cardiovasc Surg 58:215–219CrossRefPubMed
31.
Zurück zum Zitat Pinelli V, Roca E, Lucchini S et al (2015) Positron emission tomography/computed tomography for the pleural staging of malignant pleural mesothelioma: how accurate is it? Respiration 89:558–564CrossRefPubMed Pinelli V, Roca E, Lucchini S et al (2015) Positron emission tomography/computed tomography for the pleural staging of malignant pleural mesothelioma: how accurate is it? Respiration 89:558–564CrossRefPubMed
32.
Zurück zum Zitat Erasmus JJ, Truong MT, Smythe WR et al (2005) Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: staging implications. J Thorac Cardiovasc Surg 129:1364–1370CrossRefPubMed Erasmus JJ, Truong MT, Smythe WR et al (2005) Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: staging implications. J Thorac Cardiovasc Surg 129:1364–1370CrossRefPubMed
33.
Zurück zum Zitat Gerbaudo VH, Mamede M, Trotman-Dickenson B, Hatabu H, Sugarbaker DJ (2011) FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival. Eur J Nucl Med Mol Imaging 38:810–821CrossRefPubMed Gerbaudo VH, Mamede M, Trotman-Dickenson B, Hatabu H, Sugarbaker DJ (2011) FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival. Eur J Nucl Med Mol Imaging 38:810–821CrossRefPubMed
34.
Zurück zum Zitat Genestreti G, Moretti A, Piciucchi S et al (2012) FDG PET/CT response evaluation in malignant pleural mesothelioma patients treated with talc pleurodesis and chemotherapy. J Cancer 3:241–245CrossRefPubMedPubMedCentral Genestreti G, Moretti A, Piciucchi S et al (2012) FDG PET/CT response evaluation in malignant pleural mesothelioma patients treated with talc pleurodesis and chemotherapy. J Cancer 3:241–245CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Rusch VW, Rosenzweig K, Venkatraman E et al (2001) A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 122:788–795CrossRefPubMed Rusch VW, Rosenzweig K, Venkatraman E et al (2001) A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 122:788–795CrossRefPubMed
36.
Zurück zum Zitat Henley SJ, Larson TC, Wu M et al (2013) Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003–2008. Int J Occup Environ Health 19:1–10CrossRefPubMed Henley SJ, Larson TC, Wu M et al (2013) Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003–2008. Int J Occup Environ Health 19:1–10CrossRefPubMed
Metadaten
Titel
Computed tomography features of local pleural recurrence in patients with malignant pleural mesothelioma treated with intensity-modulated pleural radiation therapy
verfasst von
Darragh Halpenny
Micheal Raj
Andreas Rimner
Junting Zheng
Marinela Capanu
Michelle S. Ginsberg
Publikationsdatum
28.01.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 7/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5937-6

Weitere Artikel der Ausgabe 7/2019

European Radiology 7/2019 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.